AQR Capital Management LLC Sells 148,964 Shares of HealthEquity, Inc. (NASDAQ:HQY)

AQR Capital Management LLC reduced its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 38.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 234,681 shares of the company's stock after selling 148,964 shares during the period. AQR Capital Management LLC owned 0.27% of HealthEquity worth $22,518,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Northern Trust Corp increased its position in shares of HealthEquity by 11.7% during the fourth quarter. Northern Trust Corp now owns 1,155,043 shares of the company's stock worth $110,826,000 after buying an additional 121,001 shares during the period. Oberweis Asset Management Inc. lifted its stake in shares of HealthEquity by 8.4% in the 4th quarter. Oberweis Asset Management Inc. now owns 91,500 shares of the company's stock valued at $8,779,000 after purchasing an additional 7,100 shares during the period. Hancock Whitney Corp boosted its position in shares of HealthEquity by 1.0% during the 4th quarter. Hancock Whitney Corp now owns 13,326 shares of the company's stock valued at $1,279,000 after purchasing an additional 133 shares in the last quarter. Voya Investment Management LLC increased its holdings in HealthEquity by 70.2% in the fourth quarter. Voya Investment Management LLC now owns 78,072 shares of the company's stock worth $7,491,000 after purchasing an additional 32,204 shares in the last quarter. Finally, Adage Capital Partners GP L.L.C. acquired a new stake in shares of HealthEquity during the 4th quarter worth approximately $768,000. 99.55% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Barrington Research reissued an "outperform" rating and issued a $112.00 price objective on shares of HealthEquity in a research note on Friday, April 11th. KeyCorp dropped their price objective on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Raymond James upgraded shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and lowered their target price for the stock from $120.00 to $115.00 in a report on Tuesday, March 25th. Wells Fargo & Company increased their price objective on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 26th. Finally, The Goldman Sachs Group cut their target price on HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a research report on Thursday, March 27th. One research analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, HealthEquity has a consensus rating of "Buy" and an average target price of $111.75.

HealthEquity Stock Performance

HQY traded up $1.61 during midday trading on Wednesday, reaching $91.75. The company had a trading volume of 825,427 shares, compared to its average volume of 784,706. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59. The business has a 50-day moving average price of $88.93 and a two-hundred day moving average price of $96.62. The stock has a market cap of $7.94 billion, a PE ratio of 84.17, a P/E/G ratio of 1.60 and a beta of 0.45. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20.

Insider Buying and Selling

In other news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares in the company, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael Henry Fiore sold 8,881 shares of the company's stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the sale, the executive vice president now owns 56,655 shares in the company, valued at $4,433,820.30. The trade was a 13.55 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 20,381 shares of company stock valued at $1,781,432. 2.20% of the stock is owned by company insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.